- $48.37m
- $41.95m
- $36.26m
Annual income statement for Investview, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 March 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 38.3 | 61.8 | 67.9 | 52.4 | 36.3 |
| Cost of Revenue | |||||
| Gross Profit | 30.7 | 53.6 | 57.2 | 46.3 | 28 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 32 | 70.5 | 63.3 | 51.1 | 44.6 |
| Operating Profit | 6.25 | -8.61 | 4.6 | 1.32 | -8.37 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 0.715 | -12.6 | 5.01 | 2.09 | -8.97 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.566 | -12.9 | 2.83 | 1.19 | -8.91 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.566 | -12.9 | 2.83 | 1.19 | -8.91 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 0.344 | -13.8 | 2.01 | 0.372 | -9.73 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.001 | -0.002 | 0.001 | 0.001 | -0.005 |